WallStreetZenWallStreetZen

NASDAQ: SYRE
Spyre Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for SYRE

Based on 4 analysts offering 12 month price targets for Spyre Therapeutics Inc.
Min Forecast
$27.00-22.79%
Avg Forecast
$31.25-10.64%
Max Forecast
$35.00+0.09%

Should I buy or sell SYRE stock?

Based on 4 analysts offering ratings for Spyre Therapeutics Inc.
Strong Buy
Strong Buy
4 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SYRE stock forecasts and price targets.

SYRE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-01Find Out Why
lockedlocked$00.00+00.00%2023-12-20
lockedlocked$00.00+00.00%2023-12-18Find Out Why
lockedlocked$00.00+00.00%2023-12-11
lockedlocked$00.00+00.00%2023-12-11

1 of 1

Forecast return on equity

Is SYRE forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.53%

Forecast return on assets

Is SYRE forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

SYRE revenue forecast

What is SYRE's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.0M+12.87%
Avg 2 year Forecast
$1.0M+12.87%
Avg 3 year Forecast
$1.0M+12.87%
SYRE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SYRE revenue growth forecast

How is SYRE forecast to perform vs Biotechnology companies and vs the US market?
Company
4.12%
Industry
45.3%
Market
10.84%
SYRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SYRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SYRE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SYRE$34.97$31.25-10.64%Strong Buy
TARS$36.89$49.00+32.83%Buy
MNKD$4.65$8.00+72.04%Strong Buy
MGNX$20.72$17.00-17.95%Strong Buy
ETNB$13.77$24.75+79.74%Strong Buy

Spyre Therapeutics Stock Forecast FAQ

Is Spyre Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: SYRE) stock is to Strong Buy SYRE stock.

Out of 4 analysts, 4 (100%) are recommending SYRE as a Strong Buy, 0 (0%) are recommending SYRE as a Buy, 0 (0%) are recommending SYRE as a Hold, 0 (0%) are recommending SYRE as a Sell, and 0 (0%) are recommending SYRE as a Strong Sell.

If you're new to stock investing, here's how to buy Spyre Therapeutics stock.

What is SYRE's revenue growth forecast for 2024-2026?

(NASDAQ: SYRE) Spyre Therapeutics's forecast annual revenue growth rate of 4.12% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.84%.

Spyre Therapeutics's revenue in 2024 is $886,000.On average, 1 Wall Street analysts forecast SYRE's revenue for 2024 to be $36,150,941, with the lowest SYRE revenue forecast at $36,150,941, and the highest SYRE revenue forecast at $36,150,941. On average, 1 Wall Street analysts forecast SYRE's revenue for 2025 to be $36,150,941, with the lowest SYRE revenue forecast at $36,150,941, and the highest SYRE revenue forecast at $36,150,941.

In 2026, SYRE is forecast to generate $36,150,941 in revenue, with the lowest revenue forecast at $36,150,941 and the highest revenue forecast at $36,150,941.

What is SYRE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: SYRE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is SYRE's Price Target?

According to 4 Wall Street analysts that have issued a 1 year SYRE price target, the average SYRE price target is $31.25, with the highest SYRE stock price forecast at $35.00 and the lowest SYRE stock price forecast at $27.00.

On average, Wall Street analysts predict that Spyre Therapeutics's share price could fall to $31.25 by Mar 1, 2025. The average Spyre Therapeutics stock price prediction forecasts a potential downside of 10.64% from the current SYRE share price of $34.97.

What is SYRE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: SYRE) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.